Silverback Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $6.7M | 384k | 17.45 |
| 2024-12-31 | $4.6M | 433k | 10.55 |
| 2024-09-30 | $9.3M | 639k | 14.50 |
| 2024-06-30 | $1.1M | 134k | 8.51 |
| 2024-03-31 | $1.0M | 98k | 10.22 |
| 2023-12-31 | $591k | 108k | 5.48 |
| 2023-09-30 | $318k | 84k | 3.78 |
| 2023-06-30 | $407k | 61k | 6.70 |
| 2022-12-31 | $761k | 89k | 8.53 |
| 2022-06-30 | $947k | 238k | 3.98 |
| 2022-03-31 | $1.4M | 386k | 3.52 |
| 2021-06-30 | $410k | 13k | 31.00 |
| 2020-12-31 | $110k | 2.4k | 46.51 |